Late-onset combined immune deficiency: a subset of common variable immunodeficiency with severe T cell defect
…, R Nove-Josserand, V Lemoing, L Tetu… - Clinical Infectious …, 2009 - academic.oup.com
Background. Common variable immunodeficiency (CVID) is a primary immune deficiency
defined by defective antibody production. In most series, a small proportion of patients present …
defined by defective antibody production. In most series, a small proportion of patients present …
Granulomatous disease in CVID: retrospective analysis of clinical characteristics and treatment efficacy in a cohort of 59 patients
…, E Hachulla, J Haroche, N Schleinitz, L Têtu… - Journal of clinical …, 2013 - Springer
Background Granulomatous disease (GD) will develop in a subset of patients with common
variable immunodeficiency (CVID). Little is known about the efficacy of therapeutic agents …
variable immunodeficiency (CVID). Little is known about the efficacy of therapeutic agents …
Pulmonary hypertension in antisynthetase syndrome: prevalence, aetiology and survival
…, D Launay, M Canuet, L Têtu… - European …, 2013 - Eur Respiratory Soc
Antisynthetase syndrome is characterised by the association of interstitial lung disease and
myositis with different anti-tRNA-synthetase antibodies. The occurrence, aetiology and …
myositis with different anti-tRNA-synthetase antibodies. The occurrence, aetiology and …
New echocardiographic prognostic factors for mortality in pulmonary arterial hypertension
…, N Blot-Souletie, B Degano, L Têtu… - European Journal of …, 2010 - academic.oup.com
Aims The present role of echocardiography is generally restricted to screening for pulmonary
arterial hypertension (PAH). The aim of our study was to identify new echocardiographic …
arterial hypertension (PAH). The aim of our study was to identify new echocardiographic …
Assessment of Aspergillus sensitization or persistent carriage as a factor in lung function impairment in cystic fibrosis patients
J Fillaux, F Brémont, M Murris, S Cassaing… - … journal of infectious …, 2012 - Taylor & Francis
Background: Cystic fibrosis (CF) patients presenting with persistent carriage of, or
sensitization to, Aspergillus fumigatus are often treated with antifungal therapies because the …
sensitization to, Aspergillus fumigatus are often treated with antifungal therapies because the …
Using chest computed tomography and unsupervised machine learning for predicting and evaluating response to lumacaftor–ivacaftor in people with cystic fibrosis
…, A Didier, G Labouret, M Mittaine, L Têtu… - European …, 2022 - Eur Respiratory Soc
Objectives Lumacaftor–ivacaftor is a cystic fibrosis transmembrane conductance regulator (CFTR)
modulator known to improve clinical status in people with cystic fibrosis (CF). The aim …
modulator known to improve clinical status in people with cystic fibrosis (CF). The aim …
[HTML][HTML] Riociguat treatment in patients with chronic thromboembolic pulmonary hypertension: Final safety data from the EXPERT registry
…, T Vihinen, T Vasankari, O Sitbon, V Cottin, L Têtu… - Respiratory …, 2021 - Elsevier
Objective The soluble guanylate cyclase stimulator riociguat is approved for the treatment of
adult patients with pulmonary arterial hypertension (PAH) and inoperable or persistent/…
adult patients with pulmonary arterial hypertension (PAH) and inoperable or persistent/…
Cardiac MRI in pulmonary artery hypertension: correlations between morphological and functional parameters and invasive measurements
JP Alunni, B Degano, C Arnaud, L Tétu… - European …, 2010 - Springer
Objective To compare cardiac MRI with right heart catheterisation in patients with pulmonary
hypertension (PH) and to evaluate its ability to assess PH severity. Materials and methods …
hypertension (PH) and to evaluate its ability to assess PH severity. Materials and methods …
[HTML][HTML] Prophylaxis of invasive aspergillosis with voriconazole or caspofungin during building work in patients with acute leukemia
…, X Verdeil, MD Linas, S Cassaing, J Giron, L Tetu… - …, 2010 - ncbi.nlm.nih.gov
Background Invasive aspergillosis is a common life-threatening infection in patients with
acute leukemia. The presence of building work near to hospital wards in which these patients …
acute leukemia. The presence of building work near to hospital wards in which these patients …
[HTML][HTML] Riociguat treatment in patients with pulmonary arterial hypertension: Final safety data from the EXPERT registry
…, T Vihinen, T Vasankari, O Sitbon, V Cottin, L Têtu… - Respiratory …, 2021 - Elsevier
Objective The soluble guanylate cyclase stimulator riociguat is approved for the treatment of
adult patients with pulmonary arterial hypertension (PAH) and inoperable or persistent/…
adult patients with pulmonary arterial hypertension (PAH) and inoperable or persistent/…